Medical News

RSS

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

5 Sep 2009

microRNAs analysis could detect pancreatic cancer

A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, researchers at The University of Texas M. D. Anderson Cancer Center report in the September edition of the journal Cancer Prevention Research.

5 Sep 2009

Dems divided along regional, ideological boundaries

When it comes to health care, Democrats in specific and lawmakers in general will face deep policy differences when they return to work next week.

5 Sep 2009

Toronto nurses join In Labour Day parade

Front-line registered nurses from the Toronto area will join hundreds of union members marching in the city's Labour Day parade this long weekend.

5 Sep 2009

Genta closes second tranche offering of common stock and convertible notes

Genta Incorporated (OTCBB: GNTA) announced today that the Company has closed a second tranche of a previously announced offering with institutional investors to place Units consisting of 30% of Common Stock and 70% of Unsecured Subordinate Convertible Notes totaling $7 million in gross proceeds before fees and expenses.

5 Sep 2009

Brain protein srGAP2 capable of forming filopodia

When the process goes awry, neurodevelopmental disorders such as mental retardation, dyslexia or autism may result. Researchers at the University of North Carolina at Chapel Hill School of Medicine have now discovered that establishing the neural wiring necessary to function normally depends on the ability of neurons to make finger-like projections of their membrane called filopodia.

5 Sep 2009

Consulting Magazine ranks Impact Advisors as the Best Small Firm to Work For 2009

Each year, Consulting Magazine compiles rankings of the Best Small Firms to Work for based on feedback from the consultants who work for those firms. This year, Impact Advisors has been named as the Best Small Firm to Work For 2009. Impact Advisors was recognized for an exceptional work environment with interesting engagements while providing an outstanding work/life balance.

5 Sep 2009

Retirement planning and investing workshops for nurses

Nurses appear to be taking far better care of their patients than they are their financial futures, according to a survey released today by the Center for American Nurses and the Women's Institute for a Secure Retirement (WISER).

5 Sep 2009

Medline Industries signs agreement to acquire SunChoice

Medline Industries, Inc., the largest privately held manufacturer and distributor of medical supplies in the United States, announced today that it has signed a definitive agreement to acquire the business and assets of healthcare distributor SunChoice Europe Limited from the Southern Cross Healthcare Group.

5 Sep 2009

Researchers study tumor diversity to improve breast cancer treatment

One person's breast cancer is not the same as another person's, because the gene mutations differ in each tumor. That makes it difficult to match the best therapy with the individual patient.

5 Sep 2009

CARO and Elekta award $75,000 fellowship for lung cancer research

The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2009 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. David Palma.

From Elekta 5 Sep 2009

Securities class action lawsuit filed against Repros Therapeutics

Feazell & Tighe, L.L.P. announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities who purchased or otherwise acquired the common stock of Repros Therapeutics Inc. (“Repros” or the “Company”) (Nasdaq:RPRX), between July 1, 2009 and August 3, 2009, inclusive (the “Class Period”).

5 Sep 2009

New approach for understanding how drug resistance occurs in leukemia

UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.

5 Sep 2009

Recession impacts dental implant industry

Tooth loss among the elderly population will create some growth in the $3 billion global dental implant market despite the recession, according to "Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition" by premier life sciences market research publisher Kalorama Information, though not the impressive double digit growth rates of prior years.

5 Sep 2009

Researchers study the brain's posterior cingulate cortex

Using brain scans in monkeys, Duke University Medical Center researchers are now able to predict when monkeys will switch from exploiting a known resource to exploring their options.

5 Sep 2009

AMAG shareholders to receive rights to purchase shares under Rights Plan

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has adopted a Shareholder Rights Plan (“Rights Plan”) under which all shareholders of record as of September 17, 2009 will receive rights to purchase shares of a new series of Preferred Stock.

5 Sep 2009

Nurses urge CDC to follow the recommendations for swine flu protection from the Institute of Medicine

The California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) today applauds the Institute of Medicine for recommending strong patient safety protections for patients and caregivers to avoid airborne transmission during the ongoing H1N1/swine flu pandemic--and calls on the Centers for Disease Control to meet the same, stringent standards.

5 Sep 2009

RAC certification for 263 regulatory professionals

The Regulatory Affairs Professionals Society (RAPS) has announced that 263 regulatory professionals achieved Regulatory Affairs Certification (RAC) during the most recent exam period. The RAC credential is administered by RAPS and is the only certification specifically for regulatory professionals in the healthcare product sector.

5 Sep 2009

New role discovered for sphingosine-1-phosphate

Virginia Commonwealth University School of Medicine researchers have discovered a new role for the bioactive lipid messenger, sphingosine-1-phosphate, or S1P, that is abundant in our blood - a finding that could lead to a new generation of drugs to fight cancer and inflammatory disease.

5 Sep 2009

Google searches for 'death panels' trigger new ad war

Weeks after Sarah Palin coined the term, "death panels" to refer to a proposal in the House health reform bill, the term is among those helping to generate the most active internet advertising spree ever linked to a public policy issue, the Los Angeles Times reports.

5 Sep 2009